Diltiazem News
Regulatory issues stall Biovail's spinoff plan
TORONTO, (Reuters) - Biovail Corp.'s (BVF.TO: Quote, Profile, Research) plan to spin off its legacy products into a separate company have been delayed as it attempts to satisfy regulatory issues on both sides of the border, its...
LLNS Awarded Three Antihypertensive Products from Kos Pharmaceuticals, Inc.
LLNS/TBWA\WorldHealth has been awarded Cardizem LAÒ (diltiazem HCI tablets), TevetenÒ (eprosartan mesylate), and Teveten HCTÒ (eprosartan mesylate hydrochlorothiazide), three cardiovascular products from Kos Pharmaceuticals,...
Shurtleff fights to protect heart patients.
Attorney General Mark Shurtleff announced today that Utah has filed a lawsuit against two major drug companies for conspiring to keep a cheaper generic heart drug from consumers. The suit claims that Aventis, successor to...
FDA: Drug Name Confusion Makes Imports Dangerous
Many consumers, doctors and pharmacists are unaware that drugs sold in the United States can have the same brand name or the same sounding name as drugs sold abroad -- but with totally different ingredients, according to an alert...
Displaying results 6 to 9 out of 9